发明名称 |
RECOMBINANT ALPHAVIRUS-BASED VECTOR WITH REDUCED INHIBITION OF CELLULAR MACRO-MOLECULAR SYNTHESIS |
摘要 |
<P>PROBLEM TO BE SOLVED: To provide recombinant vectors with selected desirable phenotypes for use in a variety of applications, including for example, gene therapy and recombinant protein production, and further provide other related advantages. <P>SOLUTION: This isolated nucleic acid molecules comprise an altered alphavirus nonstructural protein gene which, when operably incorporated into a recombinant alphavirus particle, increases the time required to reach 50% inhibition of host-cell directed macromolecular synthesis following expression in mammalian cells, as compared to a wild-type alphavirus. <P>COPYRIGHT: (C)2013,JPO&INPIT |
申请公布号 |
JP2013090630(A) |
申请公布日期 |
2013.05.16 |
申请号 |
JP20120262618 |
申请日期 |
2012.11.30 |
申请人 |
NOVARTIS VACCINES & DIAGNOSTICS INC;WASHINGTON UNIV |
发明人 |
DUBENSKY THOMAS W JR;POLO JOHN M;BELLI BARBARA A;SCHLESINGER SONDRA;DRYGA SERGEY A;FROLOV ILYA |
分类号 |
C12N15/09;A61K31/7088;A61K35/76;A61K39/00;A61K48/00;A61P43/00;C07K14/18;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N7/00;C12N7/01;C12N7/04;C12N15/19;C12N15/24;C12N15/79;C12N15/86;C12P21/02 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|